Skip to main content
AAN.com

Abstract

Criteria for the diagnosis of vascular dementia (VaD) that are reliable, valid, and readily applicable in a variety of settings are urgently needed for both clinical and research purposes. To address this need, the Neuroepidemiology Branch of the National Institute of Neurological Disorders and Stroke (NINDS) convened an International Workshop with support from the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN), resulting in research criteria for the diagnosis of VaD. Compared with other current criteria, these guidelines emphasize (1) the heterogeneity of vascular dementia syndromes and pathologic subtypes including ischemic and hemorrhagic strokes, cerebral hypoxic-ischemic events, and senile leukoencephalopathic lesions; (2) the variability in clinical course, which may be static, remitting, or progressive; (3) specific clinical findings early in the course (eg, gait disorder, incontinence, or mood and personality changes) that support a vascular rather than a degenerative cause; (4) the need to establish a temporal relationship between stroke and dementia onset for a secure diagnosis; (5) the importance of brain imaging to support clinical findings; (6) the value of neuropsychological testing to document impairments in multiple cognitive domains; and (7) a protocol for neuropathologic evaluations and correlative studies of clinical, radiologic, and neuropsychological features. These criteria are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible). They await testing and validation and will be revised as more information becomes available.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Neurology®
Volume 43Number 2February 1993
Pages: 250
PubMed: 8094895

Publication History

Published online: February 1, 1993
Published in print: February 1993

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Magnitude and Time-Course of Dementia Risk in Stroke Survivors, Neurology, 104, 1, (2025)./doi/10.1212/WNL.0000000000210131
    Abstract
  2. Literaturverzeichnis zu Voderholzer (Hrsg.): Therapie psychischer Erkrankungen, 20. Auflage, Therapie psychischer Erkrankungen, (e1-e180), (2025).https://doi.org/10.1016/B978-3-437-21224-6.00055-4
    Crossref
  3. Intermittent Metabolic Switching and Vascular Cognitive Impairment, Journal of Obesity & Metabolic Syndrome, 33, 2, (92-107), (2024).https://doi.org/10.7570/jomes24010
    Crossref
  4. Systemic inflammatory markers and their association with Alzheimer’s disease: A cross-sectional analysis, Indian Journal of Psychiatry, 66, 3, (287-292), (2024).https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_975_23
    Crossref
  5. Risk of Stroke, Dementia, and Cognitive Decline with Coronary and Arterial Calcification, Journal of Clinical Medicine, 13, 14, (4263), (2024).https://doi.org/10.3390/jcm13144263
    Crossref
  6. Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights, Journal of Clinical Medicine, 13, 12, (3442), (2024).https://doi.org/10.3390/jcm13123442
    Crossref
  7. Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options, International Journal of Molecular Sciences, 25, 14, (7772), (2024).https://doi.org/10.3390/ijms25147772
    Crossref
  8. The Role of NRF2 in Cerebrovascular Protection: Implications for Vascular Cognitive Impairment and Dementia (VCID), International Journal of Molecular Sciences, 25, 7, (3833), (2024).https://doi.org/10.3390/ijms25073833
    Crossref
  9. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study, International Journal of Molecular Sciences, 25, 4, (2247), (2024).https://doi.org/10.3390/ijms25042247
    Crossref
  10. Effects of Sildenafil on Cognitive Function Recovery and Neuronal Cell Death Protection after Transient Global Cerebral Ischemia in Gerbils, Biomedicines, 12, 9, (2077), (2024).https://doi.org/10.3390/biomedicines12092077
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

Media

Figures

Other

Tables

Share

Share

Share article link

Share